Brian Lacy, PH.D; M.D

NPI: 1518980135
Total Payments
$272,238
2024 Payments
$5,286
Companies
16
Transactions
112
Medicare Patients
2,314
Medicare Billing
$278,726

Payment Breakdown by Category

Consulting$154,005 (56.6%)
Research$74,295 (27.3%)
Travel$32,231 (11.8%)
Other$5,768 (2.1%)
Education$3,000 (1.1%)
Food & Beverage$2,938 (1.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $154,005 40 56.6%
Unspecified $74,295 3 27.3%
Travel and Lodging $32,231 20 11.8%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $5,768 9 2.1%
Education $3,000 1 1.1%
Food and Beverage $2,938 39 1.1%

Payments by Type

General
$197,942
109 transactions
Research
$74,295
3 transactions

Top Paying Companies

Company Total Records Latest Year
Bausch Health US, LLC $74,295 3 $0 (2019)
Astellas Pharma Inc $42,857 13 $0 (2019)
IRONWOOD PHARMACEUTICALS, INC $40,338 19 $0 (2024)
SANOFI-AVENTIS U.S. LLC $28,249 4 $0 (2023)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $27,144 22 $0 (2024)
Ardelyx, Inc. $16,290 7 $0 (2024)
Shire North American Group Inc $13,920 15 $0 (2018)
Takeda Pharmaceuticals U.S.A., Inc. $11,414 4 $0 (2022)
Allergan, Inc. $9,805 12 $0 (2021)
US WorldMeds, LLC $3,916 5 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $5,286 3 Ardelyx, Inc. ($4,500)
2023 $22,212 9 SANOFI-AVENTIS U.S. LLC ($8,240)
2022 $33,524 14 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($14,897)
2021 $30,688 8 SANOFI-AVENTIS U.S. LLC ($16,817)
2020 $4,576 2 Takeda Pharmaceuticals U.S.A., Inc. ($4,500)
2019 $123,649 20 Bausch Health US, LLC ($74,295)
2018 $32,439 35 Shire North American Group Inc ($11,370)
2017 $19,864 21 Ironwood Pharmaceuticals, Inc ($11,736)

All Payment Transactions

112 individual payment records from CMS Open Payments — Page 1 of 5

Date Company Product Nature Form Amount Type
10/26/2024 IRONWOOD PHARMACEUTICALS, INC Linzess (Drug) Food and Beverage Cash or cash equivalent $36.21 General
Category: GI
07/01/2024 Ardelyx, Inc. IBSRELA (Drug) Consulting Fee Cash or cash equivalent $4,500.00 General
Category: GASTROENTEROLOGY
04/17/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Consulting Fee Cash or cash equivalent $750.00 General
Category: Gastroenterology
11/09/2023 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $47.19 General
Category: Gastroenterology
10/23/2023 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $67.34 General
Category: Gastroenterology
06/21/2023 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Consulting Fee Cash or cash equivalent $700.00 General
Category: Gastroenterology
06/20/2023 Mylan Inc. Consulting Fee Cash or cash equivalent $1,857.00 General
05/16/2023 Salix Pharmaceuticals, a division of Bausch Health US, LLC RELISTOR (Drug) Food and Beverage In-kind items and services $50.14 General
Category: Gastroenterology
05/15/2023 Ardelyx, Inc. IBSRELA (Drug) Education Cash or cash equivalent $3,000.00 General
Category: GASTROENTEROLOGY
04/15/2023 SANOFI-AVENTIS U.S. LLC Consulting Fee Cash or cash equivalent $8,240.00 General
03/08/2023 Ironwood Pharmaceuticals, Inc Linzess (Drug) Consulting Fee Cash or cash equivalent $6,500.00 General
Category: GI
02/14/2023 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Consulting Fee Cash or cash equivalent $1,750.00 General
Category: Gastroenterology
11/22/2022 Salix Pharmaceuticals, a division of Bausch Health US, LLC Consulting Fee Cash or cash equivalent $6,300.00 General
11/16/2022 SANOFI-AVENTIS U.S. LLC Consulting Fee Cash or cash equivalent $3,192.00 General
11/01/2022 Salix Pharmaceuticals, a division of Bausch Health US, LLC Consulting Fee Cash or cash equivalent $3,500.00 General
10/23/2022 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $164.91 General
Category: GASTROENTEROLOGY
10/14/2022 Ardelyx, Inc. IBSRELA (Drug) Consulting Fee Cash or cash equivalent $1,875.00 General
Category: GASTROENTEROLOGY
10/10/2022 Ardelyx, Inc. IBSRELA (Drug) Consulting Fee Cash or cash equivalent $750.00 General
Category: GASTROENTEROLOGY
07/19/2022 Salix Pharmaceuticals, a division of Bausch Health US, LLC Consulting Fee Cash or cash equivalent $700.00 General
06/14/2022 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Consulting Fee Cash or cash equivalent $4,200.00 General
Category: Gastroenterology
06/09/2022 Ardelyx, Inc. IBSRELA (Drug) Consulting Fee Cash or cash equivalent $3,750.00 General
Category: GASTROENTEROLOGY
05/20/2022 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $196.73 General
Category: Gastroenterology
05/11/2022 Medtronic, Inc. INTERSTIM (Device) Food and Beverage In-kind items and services $17.48 General
Category: Sacral Nerve Stimulation
03/02/2022 Ardelyx, Inc. IBSRELA (Drug) Consulting Fee Cash or cash equivalent $2,250.00 General
Category: GASTROENTEROLOGY
02/17/2022 Boston Scientific Corporation SpyGlass (Device) Food and Beverage In-kind items and services $102.73 General
Category: SpyGlass_ENDO

Research Studies & Clinical Trials

Study Name Company Amount Records
2018-3818- Lacy Bausch Health US, LLC $37,917 1
2018-3818-Lacy Bausch Health US, LLC $35,778 1
DEVELOPMENT AND VALIDATION OF A PATIENT-REPORTED OUTCOME PRO MEASURE FOR SMALL INTESTINAL BACTERIAL OVERGROWTH SIBO Bausch Health US, LLC $600.00 1

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 10 356 361 $356,348 $50,389
2022 13 551 554 $539,296 $72,918
2021 20 835 845 $197,705 $92,265
2020 13 572 588 $140,011 $63,153
Total Patients
2,314
Total Services
2,348
Medicare Billing
$278,726
Procedure Codes
56

All Medicare Procedures & Services

56 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
91299 Other diagnostic procedure for gastrointestine Office 2023 65 65 $62,836 $17,578 28.0%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 54 59 $35,636 $7,532 21.1%
91122 Study of rectum sensitivity and function Office 2023 32 32 $41,728 $6,692 16.0%
91037 Monitoring and recording of esophageal function through nasal tube with electrode Office 2023 37 37 $44,881 $4,863 10.8%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 26 26 $22,988 $4,392 19.1%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 19 19 $38,361 $3,709 9.7%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 35 35 $62,720 $3,350 5.3%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 16 16 $15,272 $1,189 7.8%
91065 Measurement of hydrogen in breath to test for stomach and bowel symptoms Office 2023 13 13 $6,084 $830.36 13.6%
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito Facility 2023 59 59 $25,842 $253.96 1.0%
91299 Other diagnostic procedure for gastrointestine Office 2022 49 49 $37,961 $17,244 45.4%
91122 Study of rectum sensitivity and function Office 2022 42 42 $54,768 $8,783 16.0%
45380 Biopsy of large bowel using a flexible endoscope Facility 2022 65 65 $113,633 $8,138 7.2%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 49 49 $43,659 $7,858 18.0%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 53 56 $33,824 $7,432 22.0%
91037 Monitoring and recording of esophageal function through nasal tube with electrode Office 2022 42 42 $50,946 $5,633 11.1%
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2022 26 26 $52,898 $5,047 9.5%
91010 Study of esophagus to assess movement Office 2022 24 24 $25,824 $4,100 15.9%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2022 18 18 $31,543 $2,455 7.8%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2022 31 31 $31,208 $2,280 7.3%
91034 Monitoring and recording of esophageal function through nasal tube Office 2022 16 16 $26,064 $2,186 8.4%
91065 Measurement of hydrogen in breath to test for stomach and bowel symptoms Office 2022 20 20 $9,360 $1,243 13.3%
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito Facility 2022 116 116 $27,608 $520.27 1.9%
91010 Measurement of esophageal swallowing movement Office 2021 65 65 $16,717 $10,489 62.7%
45380 Biopsy of the large bowel using an endoscope (colonoscopy) Facility 2021 80 80 $38,720 $9,955 25.7%

About Brian Lacy, PH.D; M.D

Brian Lacy, PH.D; M.D is a Gastroenterology healthcare provider based in Lebanon, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518980135.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brian Lacy, PH.D; M.D has received a total of $272,238 in payments from pharmaceutical and medical device companies, with $5,286 received in 2024. These payments were reported across 112 transactions from 16 companies. The most common payment nature is "Consulting Fee" ($154,005).

As a Medicare-enrolled provider, Lacy has provided services to 2,314 Medicare beneficiaries, totaling 2,348 services with total Medicare billing of $278,726. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.

Practice Information

  • Specialty Gastroenterology
  • Location Lebanon, NH
  • Active Since 07/25/2006
  • Last Updated 10/20/2020
  • Taxonomy Code 207RG0100X
  • Entity Type Individual
  • NPI Number 1518980135

Products in Payments

  • XIFAXAN (Drug) $88,843
  • IBSRELA (Drug) $16,290
  • LINZESS (Drug) $15,449
  • Linzess (Drug) $15,286
  • MOTEGRITY (Drug) $6,525
  • RIFAXIMIN (Drug) $3,766
  • Amitiza (Drug) $388.95
  • SpyGlass (Device) $102.73
  • S3 (Device) $75.52
  • RELISTOR (Drug) $50.14
  • INTERSTIM (Device) $17.48

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Gastroenterology Doctors in Lebanon